Menu Contents

PRODUCTS

A guide to all Boryung Pharmaceutical’ products.

  • Todula

    Todula [Cilnidipine] (Oral Solid, Filmcoated Tablet)

    Strength
    10mg
    Indication
    Essential hypertension
    Shelf Life
    36
    Packaging Sizes
    10T/blister(Alu-Alue)
  • Cefon

    Cefon [Cefoperazone Sodium, Sulbactam Sodium] (inj)

    Strength
    1g
    Indication
    Antibiotics
    Ceftazidime

    Ceftazidime [Ceftazidime] (inj)

    Strength
    0.5g, 1g
    Indication
    Antibiotics
    Fosfomycin

    Fosfomycin [Fosfomycin] (inj)

    Strength
    0.5g, 1g, 2g
    Indication
    Antibiotics
    Cefaclor

    Cefaclor [Cefaclor] (cap)

    Strength
    250mg
    Indication
    Antibiotics
    Packaging Sizes
    10capsules*10PTP
    Roxithromyicn

    Roxithromyicn [Roxithromycin] (tab)

    Strength
    150mg
    Indication
    Antibiotics
    Packaging Sizes
    100tablets(10tablets*10PTP), 500tablets(10tablets*50PTP)
    Fluconazole

    Fluconazole [Fluconazole] (cap)

    Strength
    50mg, 100mg
    Indication
    Antibiotics
    Packaging Sizes
    10capsules×5PTP/box
    Maxiclan

    Maxiclan [Amoxicillin, Clavulanate Potassium] (tab)

    Strength
    375mg, 625mg
    Indication
    Antibiotics
    Packaging Sizes
    375mg : 80T/box(8T/Blister*10sheet), 625mg : 40T/box(4T/Blister*10sheet)
    Methotrexate

    Methotrexate [Methotrexate ] (cap, inj)

    Strength
    2mg, 50mg/2ml
    Indication
    Antirheumaticum
    Packaging Sizes
    20capsules/box, 30capsules/box
    Amonalic duo

    Amonalic duo [Amoxicilline Clavulanate Potassium (4:1)] (syrup)

    Strength
    45.7mg/ml (7:1)
    Indication
    Antibiotics
    Shelf Life
    24
  • AD mycin

    AD mycin [Doxorubicin] (inj)

    Strength
    10mg,50mg
    Indication
    Anticancer
    Shelf Life
    24
    EP mycin

    EP mycin [Epriubicin] (inj)

    Strength
    10mg,50mg
    Indication
    Anticancer
    Shelf Life
    36
    Oxalitin

    Oxalitin [Oxaliplatin] (inj)

    Strength
    50mg,100mg
    Indication
    Anticancer
    Shelf Life
    36,24
    V.C.S.

    V.C.S. [Vincristin Sulfate] (inj)

    Strength
    1mg, 2mg
    Indication
    Anticancer
    Shelf Life
    24
    Neoplatin

    Neoplatin [Carboplatin] (inj)

    Strength
    150mg, 450mg
    Indication
    Anticancer
    Shelf Life
    24
    Placis

    Placis [Cisplatin] (inj)

    Strength
    50mg
    Indication
    Anticancer
    Shelf Life
    36
    Effcil

    Effcil [5-Fluorouracil] (inj)

    Strength
    250mg/500mg
    Indication
    Anticancer
    Shelf Life
    24
  • RE-JU(Microneedle)

    RE-JU(Microneedle) [Hyaluronic acid] (patch)

    Strength
    30um
    Indication
    Wrinkle care
    Packaging Sizes
    4Pouches/box
  • Besto

    Besto [Lafutidine 10mg] (Tab)

    Strength
    10mg
    Indication
    Histamine-2 receptor Antagonist/ Treatment gastric symptoms related acid disorder; acute/ chronic gastritis, gastric/duodenal ulcer, GERD
    Shelf Life
    36
    Packaging Sizes
    10T/blister(Alu-Alue)
    GelfosM

    GelfosM [ALPO4, Mg Hydroxide, Simethicone] (sachet)

    Strength
    20g/sachet X 4s
    Indication
    Hypergastric acidity, heartburn, gastric and duodenal ulcer, gastritis, gastralgia, nausea
    Shelf Life
    24
    Packaging Sizes
    4sachets/Box
  • Marketed API

    Marketed API
    API Therapeutic Area Spec. Polymorphic Form Serility CTD Batch Size Packing Unit GMP
    Fluconazole Antifungal EP Type II, III - KDMF 65Kg 15Kg KGMP
    Linezolid Antibacterial In-house Type IV - CTD 3Kg 3Kg KGMP
    Doxorubicin HCl Antineoplastic EP - Sterile CTD 2Kg 400g KGMP/EUGMP
    Simvastatin Cardiovascular USP - - KDMF 45Kg 10Kg KGMP
    Alacepril Cardiovascular JP - - JMF 150Kg 20Kg KGMP, PMDA
    Fimasartan potassium 3H2O Cardiovascular In-house - - NMD 300Kg 15Kg KGMP/EUGMP
    Pitavastatin Ca Cardiovascular JP Modified Type A - JMF 35Kg 1Kg KGMP, PMDA
    Donepezil HCl H2O Nervous System USP + In-house Type I - KDMF 25Kg 15Kg KGMP
    Sertraline HCl Nervous system EP Type I - JMF 100Kg 10Kg KGMP
    Montelukast sodium Respiratory USP Amorphous - JMF 35Kg 1Kg KGMP
    Tamsulosin Urology EP - - JMF 2Kg 2Kg KGMP
    Fexofenadine HCl Urology USP + In-house Type I - JMF 300Kg 10Kg KGMP, PMDA
    Aripiprazole Schizophrenia In-house Type II - JMF 20Kg 10Kg KGMP

    Pipeline API

    Pipeline API
    API Therapeutic Area Filing Status
    Dasatinib Antineoplastic Lab scale development until Jun., 2016
    Pilot batch Dec., 2016
    Ticagelor Antineoplastic Lab scale development from 2015
    Olmesartan Medoxomil Cardiovascular Lab scale development until Mar., 2014
    Rosuvastatin Ca Cardiovascular Lab scale development until Dec., 2014
    Rivaroxaban Cardiovascular Planned
    Cinacalcet HCl Hormons Lab scale development until Dec., 2015
    Pilot batch Sep., 2016
    Repaglinide Metabolism Lab scale development until Mar., 2010
    Mitiglinide Ca 2H2OMirabegron Metabolism Lab scale development until Jul., 2013
    Linagliptin Metabolism Lab scale development from 2015
    Sitagliptin phosphate H2O Metabolism Planned
    Silodosin Urinary system Lab scale development until May., 2016
    Mirabegron Urinary system Planned